OpenAI-backed biotech firm Chai Discovery raises $130M Series B at $1.3B valuation Dejar un comentario / Blog, Tech / Por henrysolis68aracsa.co.cr Chai is building foundation models for drug discovery, specifically to predict interactions between molecules so they could be reprogramed for cures.